LPL Financial’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

LPL Financial’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-66,764	Closed	-$26K	–	3551
2020 Q1	$26K	Hold	66,764	–	–	﹤0.01%	3135
2019 Q4	$27K	Sell	66,764 -14,091	-17%	-$23.4K	﹤0.01%	3299
2019 Q3	$162K	Buy	80,855 +17,000	+27%	+$34.4K	﹤0.01%	3073
2019 Q2	$138K	Buy	63,855 +40,815	+177%	+$104K	﹤0.01%	3115
2019 Q1	$73K	Buy	+23,040	New	+$74.5K	﹤0.01%	3092
2018 Q2	–	Sell	-12,300	Closed	-$29K	–	3318
2018 Q1	$29K	Buy	+12,300	New	+$19.4K	﹤0.01%	3140

LPL Financial's CORV Position: Q2 2020 in Review

LPL Financial sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 66,764 shares — an estimated $26K sold.

LPL Financial first reported a position in CORV in Q1 2018 and held it in 6 quarters. The position peaked at $162K in Q3 2019. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

LPL Financial reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
LPL Financial sold 66,764 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $26K.
LPL Financial first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2018 and held it in 6 quarters.
LPL Financial's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $162K in Q3 2019.
0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on LPL Financial's 13F filing for Q2 2020, filed 13 Aug 2020.